MedPath

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE logo
🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

63

Active:50
Completed:1

Trial Phases

4 Phases

Phase 1:36
Phase 2:1
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (42 trials with phase data)• Click on a phase to view related trials

Phase 1
36 (85.7%)
Not Applicable
3 (7.1%)
1 (2.4%)
Phase 2
1 (2.4%)
Phase 3
1 (2.4%)
No trials found

News

Okeiro Secures €10 Million to Advance AI-Driven Precision Medicine Platform for Transplantation and Chronic Diseases

Okeiro (formerly Predict4Health) has raised €10 million in funding led by Alven, Forepont Capital Partners, and Red River West to expand its AI-powered clinical decision support platform internationally.

MSInsight Secures €1.6 Million Seed Funding to Transform MSI Cancer Diagnostics

MSInsight has raised €1.6 million in seed funding to develop MSIcare, an AI-powered diagnostic solution that significantly improves detection accuracy for Microsatellite Instability (MSI) cancers.

Breakthrough Study: Endometrial Immune Profiling Boosts IVF Success Rates by 40%

A landmark randomized controlled trial by MatriceLab Innove demonstrates that personalized treatment based on endometrial immune profiling increases IVF live birth rates from 29.7% to 41.4%.

Early HIV Treatment Shows Promise for Long-Term Viral Control

Initiating antiretroviral therapy (ART) within weeks of HIV infection may allow for long-term viral control even after treatment is stopped, according to a new study.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.